Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Marilyn Manco-Johnson

Concepts (497)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
55
2026
148
11.690
 Why?
Factor VIII
35
2024
106
5.800
 Why?
Hemophilia B
14
2026
65
3.350
 Why?
Hemarthrosis
10
2020
22
3.150
 Why?
Protein C
18
2025
54
3.080
 Why?
Venous Thrombosis
14
2024
196
2.540
 Why?
Hemorrhage
27
2024
822
2.490
 Why?
Protein C Deficiency
10
2025
11
2.170
 Why?
Anticoagulants
19
2024
748
2.010
 Why?
Thrombosis
24
2024
400
2.000
 Why?
Joints
7
2026
106
1.960
 Why?
Thrombophilia
16
2022
89
1.910
 Why?
Hemostasis
7
2023
98
1.840
 Why?
Venous Thromboembolism
15
2024
328
1.820
 Why?
Factor IX
9
2016
49
1.620
 Why?
Thromboembolism
11
2016
129
1.590
 Why?
Child, Preschool
85
2026
11868
1.560
 Why?
Child
114
2026
22740
1.550
 Why?
Blood Coagulation
14
2024
274
1.510
 Why?
Infant
75
2026
10091
1.450
 Why?
Coagulants
7
2018
20
1.420
 Why?
Postthrombotic Syndrome
4
2024
13
1.360
 Why?
Adolescent
94
2026
22577
1.360
 Why?
Fibrinogen
8
2024
180
1.260
 Why?
Hemostatics
3
2022
64
1.230
 Why?
Fibrinolysis
6
2013
164
1.180
 Why?
von Willebrand Factor
6
2023
85
1.160
 Why?
Blood Coagulation Tests
13
2016
72
1.100
 Why?
Fibrinolytic Agents
12
2024
297
1.070
 Why?
Afibrinogenemia
5
2024
8
1.020
 Why?
Young Adult
42
2026
14254
0.930
 Why?
Pulmonary Embolism
7
2024
241
0.930
 Why?
Thrombolytic Therapy
6
2024
164
0.920
 Why?
Infant, Newborn
42
2024
6465
0.890
 Why?
Humans
165
2026
145783
0.880
 Why?
Male
99
2026
73010
0.750
 Why?
Antithrombin III Deficiency
4
2021
8
0.740
 Why?
Prospective Studies
28
2025
8078
0.740
 Why?
Joint Diseases
5
2019
65
0.730
 Why?
Blood Coagulation Disorders
5
2021
198
0.710
 Why?
Adult
57
2026
40881
0.700
 Why?
Pregnancy Complications, Hematologic
6
2024
24
0.700
 Why?
Quality of Life
8
2022
3211
0.670
 Why?
Antithrombins
4
2021
71
0.670
 Why?
Pain Measurement
2
2021
562
0.660
 Why?
von Willebrand Disease, Type 1
3
2017
5
0.660
 Why?
Treatment Outcome
28
2025
11794
0.650
 Why?
Factor V
7
2019
26
0.630
 Why?
Female
89
2026
79045
0.620
 Why?
Pain
2
2021
791
0.600
 Why?
Hemorrhagic Disorders
2
2018
10
0.590
 Why?
Registries
8
2025
2410
0.570
 Why?
Severity of Illness Index
10
2026
2933
0.560
 Why?
Purpura Fulminans
2
2016
2
0.550
 Why?
Blood Platelets
5
2025
379
0.540
 Why?
Drug Administration Schedule
9
2024
782
0.540
 Why?
Disseminated Intravascular Coagulation
6
2020
34
0.520
 Why?
Stroke
7
2018
1271
0.520
 Why?
Thrombin
3
2023
172
0.510
 Why?
Catheterization, Central Venous
5
2007
123
0.510
 Why?
Antiphospholipid Syndrome
5
2012
37
0.510
 Why?
Fetus
3
2023
804
0.500
 Why?
Age Factors
13
2024
3346
0.490
 Why?
Tissue Plasminogen Activator
3
2011
248
0.480
 Why?
Primary Prevention
2
2020
222
0.470
 Why?
Surveys and Questionnaires
7
2021
6085
0.470
 Why?
Blood Coagulation Factors
7
2006
71
0.440
 Why?
Risk Factors
26
2025
10919
0.440
 Why?
Population Surveillance
1
2018
484
0.420
 Why?
Case-Control Studies
12
2024
3634
0.420
 Why?
von Willebrand Diseases
2
2011
28
0.420
 Why?
Middle Aged
28
2026
36309
0.410
 Why?
Cerebral Arterial Diseases
5
2016
50
0.400
 Why?
Hyperhomocysteinemia
1
2013
26
0.390
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2013
36
0.390
 Why?
Isoantibodies
5
2016
57
0.390
 Why?
Heparin
7
2005
247
0.390
 Why?
Apoprotein(a)
1
2013
8
0.380
 Why?
Sucrose
1
2013
114
0.370
 Why?
Half-Life
3
2022
155
0.370
 Why?
Lipoprotein(a)
1
2013
69
0.360
 Why?
Brain Ischemia
5
2016
359
0.340
 Why?
Point Mutation
5
2008
241
0.340
 Why?
Blood Component Transfusion
3
2010
102
0.330
 Why?
Fibrinolysin
1
2011
19
0.330
 Why?
Aged
18
2026
26217
0.320
 Why?
Pregnancy
14
2024
7216
0.320
 Why?
United States
18
2025
16126
0.310
 Why?
Blood Loss, Surgical
1
2011
114
0.310
 Why?
Asphyxia Neonatorum
1
2010
21
0.300
 Why?
Lupus Coagulation Inhibitor
3
1999
6
0.300
 Why?
Range of Motion, Articular
3
2024
429
0.300
 Why?
Reproducibility of Results
9
2021
3418
0.300
 Why?
Biomarkers
8
2020
4302
0.300
 Why?
Elective Surgical Procedures
1
2011
203
0.300
 Why?
Colorado
12
2019
4556
0.300
 Why?
Fibrin
3
2022
84
0.290
 Why?
Time Factors
9
2025
7134
0.290
 Why?
Psychometrics
2
2019
732
0.290
 Why?
Platelet Aggregation
3
2018
99
0.290
 Why?
Antibodies, Antiphospholipid
3
2011
29
0.290
 Why?
Embolization, Therapeutic
1
2011
243
0.270
 Why?
Chickenpox
2
2001
84
0.270
 Why?
Physical Examination
2
2007
244
0.270
 Why?
Patient Satisfaction
2
2017
712
0.270
 Why?
Antibodies, Neutralizing
3
2016
340
0.270
 Why?
Fibrin Fibrinogen Degradation Products
5
2012
92
0.260
 Why?
Sheep
5
2008
876
0.260
 Why?
Postphlebitic Syndrome
1
2007
3
0.260
 Why?
Protein S
5
2002
10
0.250
 Why?
Equipment Contamination
1
2007
67
0.250
 Why?
Sports
1
2009
212
0.250
 Why?
Models, Animal
1
2008
392
0.250
 Why?
Cross-Sectional Studies
8
2026
5925
0.250
 Why?
Developmental Disabilities
1
2010
281
0.250
 Why?
Europe
2
2025
421
0.240
 Why?
Varicose Ulcer
1
2006
5
0.240
 Why?
Tumor Necrosis Factor-alpha
2
2025
1217
0.230
 Why?
Catheters, Indwelling
3
2005
96
0.230
 Why?
Infection Control
1
2007
173
0.230
 Why?
Recombinant Proteins
5
2015
1368
0.230
 Why?
Qa-SNARE Proteins
1
2025
18
0.230
 Why?
Bacteria, Anaerobic
1
2005
25
0.220
 Why?
Jugular Veins
1
2005
42
0.220
 Why?
Cognition Disorders
1
2010
544
0.220
 Why?
Thrombelastography
4
2018
192
0.220
 Why?
Recurrence
10
2024
1139
0.220
 Why?
Microfluidic Analytical Techniques
2
2017
79
0.220
 Why?
Down-Regulation
2
2025
618
0.220
 Why?
Ibuprofen
1
2005
87
0.210
 Why?
Brain Injuries
1
2010
507
0.210
 Why?
Sepsis
4
2020
664
0.210
 Why?
Hematology
1
2024
21
0.210
 Why?
Knee Joint
2
2024
429
0.210
 Why?
Health Care Surveys
1
2006
536
0.210
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2018
346
0.200
 Why?
Plasma
1
2006
223
0.200
 Why?
Prothrombin
6
2008
25
0.200
 Why?
Incidence
9
2022
2934
0.200
 Why?
Infusions, Intravenous
4
2018
428
0.200
 Why?
Amino Acid Substitution
3
2001
302
0.200
 Why?
Thrombectomy
1
2024
78
0.200
 Why?
Prevalence
8
2016
2875
0.190
 Why?
Bacterial Infections
1
2005
247
0.190
 Why?
Phenotype
6
2021
3170
0.190
 Why?
Autoantibodies
2
2001
1509
0.190
 Why?
Follow-Up Studies
10
2022
5428
0.190
 Why?
Autophagy
1
2025
291
0.190
 Why?
Athletic Injuries
1
2009
573
0.180
 Why?
Placenta
2
2023
787
0.180
 Why?
Synovitis
1
2002
35
0.180
 Why?
Mutation
10
2015
4090
0.180
 Why?
Clinical Trials as Topic
5
2010
1062
0.180
 Why?
Fetal Blood
4
2014
327
0.180
 Why?
Partial Thromboplastin Time
3
1999
53
0.170
 Why?
Blood Proteins
3
2001
239
0.170
 Why?
Administration, Oral
1
2024
867
0.170
 Why?
Intracranial Hemorrhages
2
2024
106
0.170
 Why?
Warfarin
4
2012
179
0.170
 Why?
Medical Oncology
1
2024
340
0.170
 Why?
Quality of Health Care
1
2006
693
0.160
 Why?
Diagnostic Techniques and Procedures
1
2000
19
0.160
 Why?
Cohort Studies
13
2020
6033
0.160
 Why?
Heparin Lyase
1
2000
5
0.160
 Why?
Patient Compliance
2
2003
588
0.160
 Why?
Premedication
1
2020
45
0.160
 Why?
Nigeria
1
2020
24
0.160
 Why?
Thrombophlebitis
2
1997
12
0.160
 Why?
Prognosis
7
2020
4330
0.160
 Why?
Neoplasm Proteins
2
2013
442
0.160
 Why?
Blood Specimen Collection
1
2000
37
0.160
 Why?
Platelet Function Tests
2
2017
35
0.160
 Why?
Fellowships and Scholarships
1
2024
354
0.160
 Why?
North America
1
2021
304
0.150
 Why?
Argentina
1
2019
30
0.150
 Why?
Bone Diseases
1
2020
61
0.150
 Why?
Animals, Newborn
1
2002
896
0.150
 Why?
Walking
1
2024
545
0.150
 Why?
Mutation, Missense
1
2001
335
0.150
 Why?
Practice Guidelines as Topic
4
2020
1582
0.150
 Why?
Protein S Deficiency
2
1996
8
0.150
 Why?
Factor XIII
2
2024
15
0.150
 Why?
Magnetic Resonance Imaging
5
2017
3916
0.140
 Why?
Risk
4
2013
923
0.140
 Why?
International Cooperation
2
2013
197
0.140
 Why?
Aged, 80 and over
6
2018
8347
0.140
 Why?
Heart Defects, Congenital
2
2018
910
0.140
 Why?
Antibodies
3
2013
397
0.140
 Why?
Ketorolac
1
2018
33
0.140
 Why?
Platelet Adhesiveness
1
2017
14
0.130
 Why?
Predictive Value of Tests
2
2021
2123
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
3
2014
849
0.130
 Why?
Hemorheology
1
2017
24
0.130
 Why?
Immune Tolerance
2
2015
385
0.130
 Why?
Herpesvirus 3, Human
1
2001
343
0.130
 Why?
Chondroitin Sulfates
1
2017
35
0.130
 Why?
Pediatrics
2
2024
1125
0.130
 Why?
Sensitivity and Specificity
5
2012
2000
0.130
 Why?
Observer Variation
4
2015
357
0.130
 Why?
Arthralgia
1
2017
61
0.130
 Why?
Electrocardiography
2
2018
668
0.120
 Why?
Secondary Prevention
2
2016
251
0.120
 Why?
Office Visits
1
2017
93
0.120
 Why?
Whole Genome Sequencing
1
2017
178
0.120
 Why?
Medication Adherence
2
2017
540
0.120
 Why?
Immunoglobulins
1
2016
163
0.120
 Why?
Retrospective Studies
11
2020
17330
0.120
 Why?
Area Under Curve
3
2011
332
0.120
 Why?
Fluorescent Antibody Technique
1
2016
365
0.110
 Why?
Kinetics
3
2005
1568
0.110
 Why?
Risk Assessment
4
2011
3752
0.110
 Why?
Fetal Proteins
1
1995
15
0.110
 Why?
Blood Coagulation Factor Inhibitors
1
2015
4
0.110
 Why?
Coagulation Protein Disorders
2
2008
3
0.110
 Why?
Cost of Illness
1
2017
324
0.110
 Why?
Residence Characteristics
1
2018
375
0.110
 Why?
Models, Biological
4
2024
1764
0.110
 Why?
Hemostasis, Surgical
2
2011
25
0.110
 Why?
Syndrome
2
2006
381
0.110
 Why?
Ankle Joint
2
2024
123
0.100
 Why?
Renal Veins
1
1994
18
0.100
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2014
103
0.100
 Why?
Pregnancy, Animal
1
1994
51
0.100
 Why?
Factor VIIIa
2
2006
5
0.100
 Why?
Muscle, Skeletal
1
2024
1791
0.100
 Why?
Chorioamnionitis
1
2014
50
0.100
 Why?
Contraceptives, Oral, Hormonal
2
2005
30
0.100
 Why?
Spectrum Analysis
2
2005
85
0.100
 Why?
Interleukin-8
1
2014
269
0.100
 Why?
Maternal-Fetal Exchange
1
1994
170
0.100
 Why?
Reference Values
2
2007
798
0.100
 Why?
Neoplasms
3
2024
2913
0.100
 Why?
Randomized Controlled Trials as Topic
2
2010
1752
0.090
 Why?
Fibrin Clot Lysis Time
1
2012
10
0.090
 Why?
Interleukin-1beta
1
2014
390
0.090
 Why?
Heparin, Low-Molecular-Weight
1
2012
37
0.090
 Why?
Hepatitis C
3
2013
256
0.090
 Why?
Cardiac Surgical Procedures
1
2018
611
0.090
 Why?
Migraine with Aura
1
2012
6
0.090
 Why?
Cytokines
3
2020
2069
0.090
 Why?
Quality Improvement
1
2021
1296
0.090
 Why?
Collagen Type I
1
2013
143
0.090
 Why?
Genetic Therapy
2
2005
316
0.090
 Why?
Abdomen
1
2013
142
0.090
 Why?
Polysaccharides
1
2012
86
0.090
 Why?
Canada
2
2003
432
0.090
 Why?
Preoperative Care
2
2011
380
0.090
 Why?
Enoxaparin
1
2012
68
0.090
 Why?
Nervous System Diseases
1
2014
286
0.080
 Why?
Fatal Outcome
1
2012
305
0.080
 Why?
Cerebrovascular Disorders
1
2012
105
0.080
 Why?
Immunomodulation
1
2012
99
0.080
 Why?
Edema
1
2012
125
0.080
 Why?
Research
1
2014
431
0.080
 Why?
Heart Diseases
1
2014
341
0.080
 Why?
Dose-Response Relationship, Drug
3
2016
2028
0.080
 Why?
Dependovirus
1
2011
78
0.080
 Why?
International Classification of Diseases
1
2011
150
0.080
 Why?
Polymorphism, Genetic
1
2013
615
0.080
 Why?
Hyperglycemia
1
1994
380
0.080
 Why?
Myocardial Infarction
1
2018
1211
0.080
 Why?
Interleukin-6
1
2014
780
0.080
 Why?
Phlebography
2
2008
41
0.080
 Why?
Heterozygote
2
2008
314
0.080
 Why?
Arm
1
2010
110
0.080
 Why?
Pharmacokinetics
1
2009
33
0.080
 Why?
Italy
1
2009
117
0.070
 Why?
Moyamoya Disease
1
2009
20
0.070
 Why?
Family Health
1
2010
191
0.070
 Why?
Hepatitis B
3
2013
66
0.070
 Why?
Drug Therapy, Combination
3
2016
1043
0.070
 Why?
Postoperative Care
1
2011
286
0.070
 Why?
Leg
1
2011
242
0.070
 Why?
Recombination, Genetic
1
2010
205
0.070
 Why?
Lower Extremity
1
2013
450
0.070
 Why?
Animals
8
2025
38101
0.070
 Why?
Blindness
1
2008
51
0.070
 Why?
Transcriptome
1
2015
1042
0.070
 Why?
Genotype
1
2013
1857
0.070
 Why?
Inflammation
3
2014
2884
0.070
 Why?
Thromboplastin
2
2013
67
0.070
 Why?
Smoking
1
2015
1477
0.070
 Why?
Forecasting
1
2010
390
0.070
 Why?
Cysteine Endopeptidases
2
2013
78
0.070
 Why?
Research Design
2
2015
1139
0.070
 Why?
Genetic Predisposition to Disease
4
2013
2399
0.070
 Why?
Combined Modality Therapy
1
2011
1271
0.070
 Why?
Antithrombin III
3
1994
18
0.060
 Why?
Overweight
1
2012
614
0.060
 Why?
Infant, Newborn, Diseases
1
2008
115
0.060
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2009
261
0.060
 Why?
Antibodies, Viral
1
2011
674
0.060
 Why?
Consensus
2
2024
479
0.060
 Why?
United States Food and Drug Administration
1
2008
208
0.060
 Why?
Health Surveys
2
2012
520
0.060
 Why?
Biomechanical Phenomena
2
2024
860
0.060
 Why?
Acute Disease
3
2012
1036
0.060
 Why?
History, 20th Century
1
2008
328
0.060
 Why?
Hypertension
1
2015
1276
0.060
 Why?
Kaplan-Meier Estimate
2
2022
971
0.060
 Why?
Logistic Models
4
2015
2139
0.060
 Why?
Regional Medical Programs
1
2006
6
0.060
 Why?
Blood Coagulation Disorders, Inherited
1
2006
4
0.060
 Why?
Data Collection
2
2016
643
0.060
 Why?
Age Distribution
3
2015
404
0.060
 Why?
Elbow Joint
1
2007
73
0.060
 Why?
Health Status Indicators
1
2007
167
0.060
 Why?
Ultrasonography
4
2000
788
0.060
 Why?
Fusobacterium necrophorum
1
2005
2
0.060
 Why?
Fusobacterium Infections
1
2005
7
0.060
 Why?
Computer Simulation
2
2024
1003
0.060
 Why?
Pharyngitis
1
2005
25
0.060
 Why?
Neuropsychological Tests
1
2010
1137
0.050
 Why?
Proportional Hazards Models
2
2020
1330
0.050
 Why?
Glycoproteins
3
1991
354
0.050
 Why?
DNA Mutational Analysis
2
2005
410
0.050
 Why?
Chronic Disease
1
2010
1812
0.050
 Why?
International Normalized Ratio
1
2004
55
0.050
 Why?
Regional Blood Flow
2
2017
514
0.050
 Why?
Muscle Tonus
1
2003
24
0.050
 Why?
Insulin
1
1994
2516
0.050
 Why?
Carboxypeptidase B2
1
2003
1
0.050
 Why?
Serum Globulins
1
2003
5
0.050
 Why?
Remission Induction
1
2004
306
0.050
 Why?
Radiography, Interventional
1
2024
128
0.050
 Why?
Phosphorus Radioisotopes
1
2002
25
0.050
 Why?
Guatemala
1
2024
343
0.050
 Why?
Delivery, Obstetric
1
2024
160
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2003
85
0.050
 Why?
Automation
1
2003
104
0.050
 Why?
Liver Diseases
1
2006
305
0.050
 Why?
Radionuclide Imaging
1
2002
116
0.050
 Why?
Elbow
1
2002
56
0.050
 Why?
Sex Factors
3
2013
2110
0.050
 Why?
Blood Sedimentation
1
2022
37
0.040
 Why?
Transfusion Reaction
1
2002
61
0.040
 Why?
Acceleration
1
2022
33
0.040
 Why?
Therapeutics
1
2022
14
0.040
 Why?
Knee
1
2002
72
0.040
 Why?
Ankle
1
2002
64
0.040
 Why?
Drug Costs
1
2003
117
0.040
 Why?
Obesity
2
2013
3118
0.040
 Why?
Injections
1
2002
199
0.040
 Why?
Liver Failure, Acute
1
2002
68
0.040
 Why?
Factor X
1
2001
26
0.040
 Why?
Algorithms
2
2011
1851
0.040
 Why?
Hormone Replacement Therapy
1
2002
107
0.040
 Why?
Clinical Laboratory Techniques
1
2002
96
0.040
 Why?
Quality Assurance, Health Care
2
2015
342
0.040
 Why?
Body Weight
1
2006
972
0.040
 Why?
Phosphatidylserines
1
2001
62
0.040
 Why?
Pregnancy Outcome
1
2005
504
0.040
 Why?
Developing Countries
1
2003
317
0.040
 Why?
Diagnostic Imaging
2
2015
337
0.040
 Why?
RNA, Messenger
2
2002
2805
0.040
 Why?
Hospitalization
1
2011
2461
0.040
 Why?
Exercise Therapy
1
2006
475
0.040
 Why?
Diagnostic Equipment
1
2000
5
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2181
0.040
 Why?
Phosphatidylcholines
1
2001
131
0.040
 Why?
Diagnosis, Differential
2
2017
1512
0.040
 Why?
Self Care
1
2003
392
0.040
 Why?
Priapism
1
2000
10
0.040
 Why?
Evaluation Studies as Topic
1
2000
164
0.040
 Why?
Statistics as Topic
1
2001
283
0.040
 Why?
Purpura
2
1990
18
0.040
 Why?
False Negative Reactions
1
2000
61
0.040
 Why?
Drug Eruptions
1
2000
28
0.040
 Why?
Vitamin K
2
1999
46
0.040
 Why?
Cardiovascular Diseases
1
2012
2191
0.040
 Why?
Longitudinal Studies
2
2007
2968
0.040
 Why?
Veins
1
2000
69
0.040
 Why?
Quality Control
1
2000
161
0.040
 Why?
Prothrombin Time
1
1999
33
0.040
 Why?
Plethysmography
1
2000
104
0.040
 Why?
HIV Seronegativity
1
1999
29
0.040
 Why?
Gene Expression Regulation, Developmental
1
2005
910
0.040
 Why?
False Positive Reactions
1
1999
123
0.040
 Why?
Cost-Benefit Analysis
1
2002
644
0.040
 Why?
Vasoconstrictor Agents
1
2020
150
0.040
 Why?
Liposomes
1
2001
263
0.040
 Why?
Sheep Diseases
1
1999
9
0.040
 Why?
Comorbidity
2
2015
1662
0.040
 Why?
Disease Progression
1
2007
2865
0.040
 Why?
Motor Activity
1
2003
718
0.030
 Why?
Mitochondria
1
2025
993
0.030
 Why?
Age of Onset
2
2010
557
0.030
 Why?
ROC Curve
1
2020
618
0.030
 Why?
Therapeutic Equivalency
1
2018
31
0.030
 Why?
Time-to-Treatment
1
2020
251
0.030
 Why?
Asia
1
2018
70
0.030
 Why?
Mice, Knockout
1
2025
3130
0.030
 Why?
Disease Models, Animal
1
2008
4568
0.030
 Why?
Deamino Arginine Vasopressin
1
2017
15
0.030
 Why?
Factor VII
2
2013
24
0.030
 Why?
Intensive Care Units, Pediatric
1
2020
288
0.030
 Why?
Bone and Bones
1
2020
318
0.030
 Why?
Postoperative Period
1
2018
351
0.030
 Why?
Drug Resistance
1
1997
145
0.030
 Why?
Chromosome Disorders
1
1997
47
0.030
 Why?
Chromosome Aberrations
1
1997
166
0.030
 Why?
Pedigree
2
1996
515
0.030
 Why?
Arginine
1
1997
264
0.030
 Why?
Comparative Genomic Hybridization
1
2016
28
0.030
 Why?
Models, Theoretical
1
2019
560
0.030
 Why?
Blood Flow Velocity
1
2017
421
0.030
 Why?
Erythrocytes
1
2022
749
0.030
 Why?
Injections, Subcutaneous
1
2016
170
0.030
 Why?
Patient-Centered Care
1
2021
547
0.030
 Why?
Odds Ratio
2
2013
1083
0.030
 Why?
Plasmapheresis
1
2015
24
0.030
 Why?
Streptococcus pyogenes
1
1996
41
0.030
 Why?
Intracranial Embolism and Thrombosis
1
1995
7
0.030
 Why?
Decision Making
1
2003
982
0.030
 Why?
Stress, Mechanical
1
2017
494
0.030
 Why?
Models, Immunological
1
2015
99
0.030
 Why?
Cross-Over Studies
1
2018
610
0.030
 Why?
Florida
1
2015
117
0.030
 Why?
Embryonic and Fetal Development
1
1995
93
0.030
 Why?
Respiration, Artificial
1
2020
714
0.030
 Why?
Endpoint Determination
1
2015
85
0.030
 Why?
Causality
1
2015
127
0.030
 Why?
Parents
1
2003
1407
0.030
 Why?
Single-Blind Method
1
2015
318
0.030
 Why?
Sex Distribution
1
2015
388
0.030
 Why?
Neuroimaging
1
2016
300
0.030
 Why?
Polymerase Chain Reaction
1
1997
1043
0.030
 Why?
Factor VIIa
1
2013
43
0.020
 Why?
Propensity Score
1
2015
377
0.020
 Why?
Public Health Surveillance
1
2013
83
0.020
 Why?
Streptococcal Infections
1
1996
171
0.020
 Why?
Microfluidics
1
2013
61
0.020
 Why?
Sequence Analysis, DNA
1
2016
778
0.020
 Why?
Gestational Age
2
2014
990
0.020
 Why?
Mice
2
2025
18355
0.020
 Why?
Vena Cava, Inferior
1
2013
83
0.020
 Why?
Immunoglobulin G
1
2016
892
0.020
 Why?
Heparin Cofactor II
1
1991
1
0.020
 Why?
Chi-Square Distribution
1
2013
528
0.020
 Why?
Horses
1
2013
226
0.020
 Why?
Parvoviridae Infections
1
2011
12
0.020
 Why?
Homozygote
3
2003
199
0.020
 Why?
Cardiology
1
2014
362
0.020
 Why?
Protein Deficiency
1
1990
4
0.020
 Why?
Seroepidemiologic Studies
1
2011
171
0.020
 Why?
Feasibility Studies
1
2015
1115
0.020
 Why?
Complement Inactivator Proteins
1
1990
39
0.020
 Why?
Immunosuppressive Agents
1
2015
838
0.020
 Why?
Genetic Variation
1
2016
977
0.020
 Why?
Carrier Proteins
2
1991
729
0.020
 Why?
Liver
2
1999
1899
0.020
 Why?
Health Status Disparities
1
2013
321
0.020
 Why?
Delphi Technique
1
2011
333
0.020
 Why?
Genetic Vectors
1
2011
335
0.020
 Why?
Perioperative Care
1
2012
231
0.020
 Why?
Pilot Projects
1
2015
1898
0.020
 Why?
Molecular Weight
1
1989
312
0.020
 Why?
Multivariate Analysis
1
2013
1547
0.020
 Why?
Glucose
1
1994
1049
0.020
 Why?
Germany
1
2009
138
0.020
 Why?
Recovery of Function
1
2013
716
0.020
 Why?
Multicenter Studies as Topic
1
2009
413
0.020
 Why?
Twins
1
1988
152
0.020
 Why?
C-Reactive Protein
1
2009
423
0.020
 Why?
Vitamin K Deficiency
1
1986
9
0.020
 Why?
Evidence-Based Medicine
1
2010
740
0.020
 Why?
Polycystic Kidney Diseases
1
1987
71
0.010
 Why?
Kidney
1
1994
1497
0.010
 Why?
Protein Precursors
1
1986
136
0.010
 Why?
Endopeptidases
1
1986
80
0.010
 Why?
Cell Line
1
2011
2823
0.010
 Why?
Global Health
1
2008
403
0.010
 Why?
Postoperative Complications
1
1997
2977
0.010
 Why?
Wounds and Injuries
1
2013
962
0.010
 Why?
Body Mass Index
1
2013
2447
0.010
 Why?
Aging
1
1995
1973
0.010
 Why?
Introns
1
2005
256
0.010
 Why?
Exons
1
2005
364
0.010
 Why?
Antibody Formation
1
2005
288
0.010
 Why?
Abortion, Habitual
1
2002
4
0.010
 Why?
HIV Infections
2
2013
3195
0.010
 Why?
Arterial Occlusive Diseases
1
2003
90
0.010
 Why?
Acquired Immunodeficiency Syndrome
1
2001
237
0.010
 Why?
Necrosis
1
2000
244
0.010
 Why?
Factor X Deficiency
1
1999
3
0.010
 Why?
Counterimmunoelectrophoresis
1
1999
3
0.010
 Why?
Thrombin Time
1
1999
13
0.010
 Why?
Genes, Recessive
1
1999
78
0.010
 Why?
Immunoelectrophoresis, Two-Dimensional
2
1990
4
0.010
 Why?
Blotting, Western
1
2000
1184
0.010
 Why?
Base Sequence
1
2000
2171
0.010
 Why?
Molecular Sequence Data
1
2000
2883
0.010
 Why?
Urography
1
1987
19
0.000
 Why?
Genes, Dominant
1
1987
100
0.000
 Why?
Infant, Small for Gestational Age
1
1986
118
0.000
 Why?
Serine Endopeptidases
1
1986
129
0.000
 Why?
Protein Binding
1
1986
2240
0.000
 Why?
Manco-Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (497) concept(s)
_
Co-Authors Expand Description
See all (40) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)